Celiac Disease
Celiac Study Participants Needed
New York City – Columbia Presbyterian University Study
Join A Study on The Effect of a Gluten-Free Diet on Bone Density
Are you newly diagnosed with celiac disease?
If so, you may be eligible to join a study being done at Columbia Presbyterian University Medical Center examining the impact of celiac disease on your skeleton and following the effect of a gluten-free diet on density and quality.
Osteoporosis is one of the most common complications of celiac disease. And, approximately 75% of newly diagnosed patients with CD have some degree of bone loss.
Dr. Elizabeth Shane, Professor of Medicine at the Metabolic Bone Diseases Unit is working with Dr. Peter Green, Director of the Celiac Disease Center to examine the effect of a gluten-free diet on bone growth and regeneration. They will be utilizing a new machine that can actually "see" the structure and matrix of the inside of the bone as well as its density.
If you are:
1- Not yet on a gluten-free diet or have been on the diet for no more than ONE month
2- Able to travel to Columbia University Medical Center Columbia Presbyterian in NYC
3- Interested in more information,
Please contact: Halley Eisenberg At : (212) 342-5725
Interested in Celiac Research? Diagnosed with Celiac Disease? On a gluten-free diet for a least 6 months? Willing to complete 7 study visits in 10 weeks? Between the ages of 18-72?
If you answered yes to these questions, you may qualify for a clinical research trial designed to study a new investigational medication for Celiac Disease. To obtain more information or to find a study site near you, send an email to clintrials@albatherapeutics.com or call 1-877-415-3282
Los Angeles area -- Have you had a bone screening lately? go
Have you had an Upper GI Endoscopy?
Your opinion is needed - click here
CELIAC FAMILY STUDY
Irvine, California
DOES YOUR FAMILY STRUGGLE WITH CELIAC DISEASE OR DERMATITIS HERPETIFORMIS? YOUR PARTICIPATION COULD HELP RESEARCHERS IDENTIFY GENES FOR THIS CONDITION.
Investigators at the University of California, Irvine are seeking families with at least two individuals who have been diagnosed with celiac sprue or dermatitis herpetiformis to participate in a genetic study of celiac disease. The study is designed to identify factors associated with celiac disease and to find genes that may predispose individuals and their relatives to develop this condition. The discovery of such genes may one day lead to better diagnosis, treatment, and possibly even prevention of celiac disease.
Families eligible to participate in this celiac study must have at least two relatives (with the exception of simple parent-child pairs) diagnosed with celiac sprue or dermatitis herpetiformis by at least one of the following methods: a small intestinal biopsy, a positive transglutaminase (tTG) antibody test, a positive endomysial (EMA) antibody test, or a positive skin biopsy (for dermatitis herpetiformis). After meeting the eligibility criteria to enroll a family, all first degree relatives of those who have been diagnosed with celiac sprue or dermatitis herpetiformis will be invited to participate in the study. These participants will receive a free antibody test for screening of celiac disease if they are not currently on a gluten free diet and have not recently been tested for celiac sprue.
If you are interested in participating, or have questions about the study, please contact Maryam Mousavi, University of California, Irvine at (949)824-5603 or toll-free at (866)356-9962, or e-mail mmousavi@uci.edu.
